Literature DB >> 25696796

Interobserver variability of mitotic index and utility of PHH3 for risk stratification in gastrointestinal stromal tumors.

Ahmad Alkhasawneh1, John D Reith1, Tania Zuluaga Toro1, Ayed O Ayed2, Xiaomin Lu3, Thomas J George2, Lizette Vila Duckworth4.   

Abstract

OBJECTIVES: Accurate grading of gastrointestinal stromal tumors (GISTs), based on mitotic index, can be problematic.
METHODS: In this study, we compared interobserver variability in detecting mitosis on H&E with PHH3 immunohistochemistry (IHC). In addition, we examined the correlation between H&E mitosis and Ki-67 and the association of PHH3 and Ki-67 with overall survival. Four pathologists independently reviewed 50 GIST cases.
RESULTS: Intraclass correlation coefficients showed good interobserver variability for mitotic counts on both H&E (0.918; 95% confidence interval [CI], 0.874-0.950) and PHH3 IHC (0.923; 95% CI, 0.882-0.953). Nineteen (38%) cases were graded higher and five (10%) cases were downgraded by at least one observer using PHH3 compared with H&E. Using receiver operating characteristic curve analysis, a PHH3 cutoff of seven or more mitoses was associated with worse overall survival (P = .028). Ki-67 showed poor correlation with H&E mitotic counts and overall survival (P = .077).
CONCLUSIONS: PHH3 may thus be a valuable adjunct for risk stratification in GISTs. Copyright© by the American Society for Clinical Pathology.

Entities:  

Keywords:  Anti–phosphohistone H3; Gastrointestinal stromal tumors; Ki-67; Mitoses; Soft tissue

Mesh:

Substances:

Year:  2015        PMID: 25696796     DOI: 10.1309/AJCPAPH28VHZEKNQ

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  pSlugS158 immunohistochemistry is a novel promising mitotic marker for FFPE samples: a pilot study.

Authors:  Chang Gok Woo; Seung-Myoung Son; Young Hyun Lim; Dakeun Lee; Jung-Jin Park; Eung-Gook Kim; Eun-Young Shin; Ok-Jun Lee
Journal:  Virchows Arch       Date:  2021-09-11       Impact factor: 4.064

2.  Can PPH3 be helpful to assess the discordant grade in primary and metastatic enteropancreatic neuroendocrine tumors?

Authors:  Clotilde Dumars; Fanny Foubert; Yann Touchefeu; Nicolas Regenet; Hélène Senellart; Tamara Matysiak-Budnik; Marie-Françoise Heymann
Journal:  Endocrine       Date:  2016-04-05       Impact factor: 3.633

3.  Protein biomarker of cell proliferation determines survival to discharge in cases of equine large colon volvulus.

Authors:  C R Kucera; L W Stranahan; F Hughes; A T Blikslager; L M Gonzalez
Journal:  Equine Vet J       Date:  2017-11-27       Impact factor: 2.888

4.  Phosphohistone H3 (pHH3) is a prognostic and epithelial to mesenchymal transition marker in diffuse gliomas.

Authors:  Ping Zhu; Chuan-Bao Zhang; Pei Yang; Jing Chen; Yu-Qing Liu; Hui-Min Hu; Hua Huang; Zhao-Shi Bao; Wei Zhang; Wei-Jia Kong; Tao Jiang
Journal:  Oncotarget       Date:  2016-07-19

5.  Identification of Phosphohistone H3 Cutoff Values Corresponding to Original WHO Grades but Distinguishable in Well-Differentiated Gastrointestinal Neuroendocrine Tumors.

Authors:  Min Jeong Kim; Mi Jung Kwon; Ho Suk Kang; Kyung Chan Choi; Eun Sook Nam; Seong Jin Cho; Hye-Rim Park; Soo Kee Min; Jinwon Seo; Ji-Young Choe; Hyoung-Chul Park
Journal:  Biomed Res Int       Date:  2018-03-27       Impact factor: 3.411

6.  Pooling analysis on prognostic value of PHH3 expression in cancer patients.

Authors:  Qian Hao; Cong Dai; Yujiao Deng; Peng Xu; Tian Tian; Shuai Lin; Meng Wang; Kang Liu; Dingli Song; Ying Wu; Yan Guo; Zhijun Dai
Journal:  Cancer Manag Res       Date:  2018-07-30       Impact factor: 3.989

7.  Mitotic Activity in Gastrointestinal Stromal Tumors: Can we use Phosphohistone H3 Immunohistochemistry Instead of Hematoxylin and Eosin for Mitotic Count?

Authors:  Selma Sengiz Erhan; Sibel Sensu; Sevinc Hallac Keser; Elis Kangal; Aylin Ege Gul; Gokcen Alinak Gundogan; Abdullah Sakin
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2022-06-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.